
Pfizer CEO Albert Bourla says that the company is prepared for a novel covid-19 variant which could evade protection provided by the vaccine.
Greg Heilman
Pfizer CEO Albert Bourla says that the company is prepared for a novel covid-19 variant which could evade protection provided by the vaccine.